In the 44 (52%) patients who developed AKI as defined by the risk, injury, failure, loss, and end-stage (RIFLE) criteria, cystatin C levels detected AKI (defined by a 50% increase from baseline) 1.5 ± 0.6 days earlier than serum creatinine. Here, CST3 is linked to acute kidney injury.